Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection

Multiclass-drug resistance, often caused by poor treatment compliance, is a challenging problem in all categories of HIV-infected patients. Selective pressure is higher in youth for both biological and behavioral reasons. We report the case of a 15-year-old Caucasian male, with vertically acquired H...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosso, R, Bernardini, C, Bruzzone, B, Secondo, G, Icardi, G, Viscoli, C, Di Biagio, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352063/
https://www.ncbi.nlm.nih.gov/pubmed/19380285
http://dx.doi.org/10.1186/2047-783X-14-3-136
_version_ 1782232839891189760
author Rosso, R
Bernardini, C
Bruzzone, B
Secondo, G
Icardi, G
Viscoli, C
Di Biagio, A
author_facet Rosso, R
Bernardini, C
Bruzzone, B
Secondo, G
Icardi, G
Viscoli, C
Di Biagio, A
author_sort Rosso, R
collection PubMed
description Multiclass-drug resistance, often caused by poor treatment compliance, is a challenging problem in all categories of HIV-infected patients. Selective pressure is higher in youth for both biological and behavioral reasons. We report the case of a 15-year-old Caucasian male, with vertically acquired HIV-1 infection, who failed several lines of antiretroviral therapy and was successfully treated with darunavir/ritonavir and etravirine.
format Online
Article
Text
id pubmed-3352063
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33520632012-05-16 Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection Rosso, R Bernardini, C Bruzzone, B Secondo, G Icardi, G Viscoli, C Di Biagio, A Eur J Med Res Case Report Multiclass-drug resistance, often caused by poor treatment compliance, is a challenging problem in all categories of HIV-infected patients. Selective pressure is higher in youth for both biological and behavioral reasons. We report the case of a 15-year-old Caucasian male, with vertically acquired HIV-1 infection, who failed several lines of antiretroviral therapy and was successfully treated with darunavir/ritonavir and etravirine. BioMed Central 2009-03-17 /pmc/articles/PMC3352063/ /pubmed/19380285 http://dx.doi.org/10.1186/2047-783X-14-3-136 Text en Copyright ©2009 I. Holzapfel Publishers
spellingShingle Case Report
Rosso, R
Bernardini, C
Bruzzone, B
Secondo, G
Icardi, G
Viscoli, C
Di Biagio, A
Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection
title Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection
title_full Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection
title_fullStr Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection
title_full_unstemmed Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection
title_short Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection
title_sort efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically hiv-1 infection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352063/
https://www.ncbi.nlm.nih.gov/pubmed/19380285
http://dx.doi.org/10.1186/2047-783X-14-3-136
work_keys_str_mv AT rossor efficacyandsafetyofdarunavirandetravirineinanantiretroviralmultiexperiencedyouthwithverticallyhiv1infection
AT bernardinic efficacyandsafetyofdarunavirandetravirineinanantiretroviralmultiexperiencedyouthwithverticallyhiv1infection
AT bruzzoneb efficacyandsafetyofdarunavirandetravirineinanantiretroviralmultiexperiencedyouthwithverticallyhiv1infection
AT secondog efficacyandsafetyofdarunavirandetravirineinanantiretroviralmultiexperiencedyouthwithverticallyhiv1infection
AT icardig efficacyandsafetyofdarunavirandetravirineinanantiretroviralmultiexperiencedyouthwithverticallyhiv1infection
AT viscolic efficacyandsafetyofdarunavirandetravirineinanantiretroviralmultiexperiencedyouthwithverticallyhiv1infection
AT dibiagioa efficacyandsafetyofdarunavirandetravirineinanantiretroviralmultiexperiencedyouthwithverticallyhiv1infection

Ejemplares similares